Losing Weight with Semaglutide It is a GLP-1 (glucagon-like-peptide-1) receptor agonist
What Is the Nutritional Approach
While mild gastrointestinal (GI) side effects like nausea, vomiting, diarrhea, and abdominal discomfort are reported and tend to improve over time, there is also potential for other severe ADEs, such as gastroparesis and GI obstruction, which often require hospitalization, particularly in the context of surgical interventions
"Just like Wegovy, all weight loss medication will need FDA approval for treating a weight-related health condition, not just weight loss itself," Yu said
Related strategies to synchronize circadian rhythms are aimed at eating during daylight hours, altering calorie distribution across the day, and eating regularly